Literature DB >> 26752217

Growth hormone actions during development influence adult phenotype and longevity.

A Bartke1, L Sun2, Y Fang2, C Hill2.   

Abstract

There is considerable evidence that exposure to undernutrition, overnutrition, stress or endocrine disruptors during fetal development can increase the probability of obesity, hypertension, cardiovascular disease and other problems in adult life. In contrast to these findings, reducing early postnatal growth by altering maternal diet or number of pups in a litter can increase longevity. In hypopituitary Ames dwarf mice, which are remarkably long lived, a brief period of growth hormone therapy starting at 1 or 2weeks of age reduces longevity and normalizes ("rescues") multiple aging-related traits. Collectively, these findings indicate that nutritional and hormonal signals during development can have profound impact on the trajectory of aging. We suspect that altered "programming" of aging during development may represent one of the mechanisms of the Developmental Origins of Health and Disease (DOHaD) and the detrimental effects of "catch-up" growth.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Ames dwarf mice; Developmental origin of disease; Developmental programming; Growth hormone; Litter crowding; Nutrition

Mesh:

Substances:

Year:  2016        PMID: 26752217      PMCID: PMC4930735          DOI: 10.1016/j.exger.2015.12.011

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  61 in total

1.  Hormone-treated snell dwarf mice regain fertility but remain long lived and disease resistant.

Authors:  Maggie Vergara; Michael Smith-Wheelock; James M Harper; Robert Sigler; Richard A Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-12       Impact factor: 6.053

2.  Non-Programmed Versus Programmed Aging Paradigm.

Authors:  Giacinto Libertini
Journal:  Curr Aging Sci       Date:  2015-04-22

3.  Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span.

Authors:  William E Sonntag; Christy S Carter; Yuji Ikeno; Kari Ekenstedt; Cathy S Carlson; Richard F Loeser; Shilla Chakrabarty; Shuko Lee; Colleen Bennett; Rhonda Ingram; Tracy Moore; Melinda Ramsey
Journal:  Endocrinology       Date:  2005-03-24       Impact factor: 4.736

Review 4.  Fetal nutrition and cardiovascular disease in adult life.

Authors:  D J Barker; P D Gluckman; K M Godfrey; J E Harding; J A Owens; J S Robinson
Journal:  Lancet       Date:  1993-04-10       Impact factor: 79.321

Review 5.  Impact of maternal obesity on offspring obesity and cardiometabolic disease risk.

Authors:  Amanda J Drake; Rebecca M Reynolds
Journal:  Reproduction       Date:  2010-06-18       Impact factor: 3.906

6.  Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults.

Authors:  Joselina L M Oliveira; Manuel H Aguiar-Oliveira; Argemiro D'Oliveira; Rossana M C Pereira; Carla R P Oliveira; Catarine T Farias; José A Barreto-Filho; Fernando D Anjos-Andrade; Celi Marques-Santos; Adão C Nascimento-Junior; Erica O Alves; Francielle T Oliveira; Viviane C Campos; Roberto Ximenes; Amanda Blackford; Giovanni Parmigiani; Roberto Salvatori
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

7.  Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1.

Authors:  Jun H Park; Doris A Stoffers; Robert D Nicholls; Rebecca A Simmons
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

8.  Effects of chronic hyperthyroidism on the lifespan of the rat.

Authors:  H Ooka; T Shinkai
Journal:  Mech Ageing Dev       Date:  1986-02       Impact factor: 5.432

9.  Growth hormone-releasing hormone disruption extends lifespan and regulates response to caloric restriction in mice.

Authors:  Liou Y Sun; Adam Spong; William R Swindell; Yimin Fang; Cristal Hill; Joshua A Huber; Jacob D Boehm; Reyhan Westbrook; Roberto Salvatori; Andrzej Bartke
Journal:  Elife       Date:  2013-10-29       Impact factor: 8.140

10.  Morphology of ovaries in laron dwarf mice, with low circulating plasma levels of insulin-like growth factor-1 (IGF-1), and in bovine GH-transgenic mice, with high circulating plasma levels of IGF-1.

Authors:  Sylwia Słuczanowska-Głąbowska; Maria Laszczyńska; Katarzyna Piotrowska; Wojciech Głąbowski; John J Kopchick; Andrzej Bartke; Magda Kucia; Mariusz Z Ratajczak
Journal:  J Ovarian Res       Date:  2012-07-02       Impact factor: 4.234

View more
  3 in total

Review 1.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

2.  Differential effects of early-life nutrient restriction in long-lived GHR-KO and normal mice.

Authors:  Yimin Fang; Samuel McFadden; Justin Darcy; Cristal M Hill; Joshua A Huber; Steve Verhulst; John J Kopchick; Richard A Miller; Liou Y Sun; Andrzej Bartke
Journal:  Geroscience       Date:  2017-05-18       Impact factor: 7.713

Review 3.  Sex Differences in Lifespan.

Authors:  Steven N Austad; Kathleen E Fischer
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.